Arkolith/Insider Trading/RYTM/Form 4

Smith Hunter C

Chief Financial OfficerRHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed Feb 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$703K
Net Open-Market Flow
-$703K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2026Sell(S)3K$106.06$359K126K
Feb 4, 2026Sell(S)2K$104.74$157K131K
Feb 4, 2026Sell(S)747$107.67$80K129K
Feb 4, 2026Sell(S)1K$106.60$107K130K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-011651) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML